BioProtect

Founded: 2001 • Age: 25 yrs
Radiation protection technology is developed for prostate cancer radiotherapy.
Request Access

About BioProtect

BioProtect is a company founded in 2001 by Shaul Shohat and Adrian Paz.. BioProtect has raised $46.1 million across 9 funding rounds from investors including Medtronic, European Union and KB Investment. BioProtect offers products and services including BioProtect Balloon Implant System. BioProtect operates in a competitive market with competitors including Lucerno Dynamics, SpaceOAR hydrogel, Quality Electrodynamics, m2m Imaging Corp. and EXACT Therapeutics, among others.

  • Founders Shaul Shohat, Adrian Paz
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bioprotect Medical Inc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $46.1 M (USD)

    in 9 rounds

  • Latest Funding Round
    $2.65 M (USD), Grant

    Oct 01, 2023

  • Investors
    Medtronic

    & 8 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BioProtect

BioProtect offers a comprehensive portfolio of products and services, including BioProtect Balloon Implant System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Biodegradable balloon for spacing rectal wall during prostate radiotherapy.

People of BioProtect
Headcount 10-50
Employee Profiles 15
Board Members and Advisors 5
Employee Profiles
People
Itay Barnea
CEO At Bioprotect
People
Shaul Shohat
Co-Founder & CTO
People
Lee Adler
Chief Operating Officer
People
Shahar Shaked
VP Finance & Administration

Unlock access to complete

Funding Insights of BioProtect

BioProtect has successfully raised a total of $46.1M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $2.65 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 9
  • Last Round Grant — $2.6M
  • First Round

    (18 Oct 2004)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2023 Amount Grant - BioProtect Valuation

investors

Sep, 2020 Amount Series D - BioProtect Valuation Vincent Tchenguiz , Almeda Ventures
Jan, 2020 Amount Series D - BioProtect Valuation KB Investment , Accelmed Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioProtect

BioProtect has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Medtronic, European Union and KB Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Peregrine is focused on healthcare innovation through strategic global investments.
Founded Year Domain Location
Venture capital fund investing in early-stage tech startups
Founded Year Domain Location
Investments in health tech sectors are managed by Almeda Ventures.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioProtect

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BioProtect

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioprotect Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioProtect

BioProtect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lucerno Dynamics, SpaceOAR hydrogel, Quality Electrodynamics, m2m Imaging Corp. and EXACT Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Imaging technology for radiotracer quality assessment is developed.
domain founded_year HQ Location
Rectal protection hydrogel for prostate cancer radiation therapy is provided.
domain founded_year HQ Location
Magnetic resonance equipment and accessories for clinical diagnosis
domain founded_year HQ Location
Preclinical MRI Imaging Devices and Accessories
domain founded_year HQ Location
Sonoporation platform is provided for diagnosing multiple diseases.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioprotect

Frequently Asked Questions about BioProtect

When was BioProtect founded?

BioProtect was founded in 2001 and raised its 1st funding round 3 years after it was founded.

Is BioProtect a funded company?

BioProtect is a funded company, having raised a total of $46.1M across 9 funding rounds to date. The company's 1st funding round was a Series D of $13M, raised on Oct 18, 2004.

What does BioProtect do?

BioProtect was founded in 2001 as a developer of radiation protection solutions in the medical technology sector. The BioProtectProSpace Balloon System has been created to serve as a spacer, displacing healthy tissue from high-dose radiation areas during prostate cancer treatments. Operations focus on advancing radiotherapy accessories, with co-founders Shaul Shohat as CTO and Adrian Paz leading the efforts. No specific geographic base is indicated.

Who are the top competitors of BioProtect?

BioProtect's top competitors include EXACT Therapeutics, Quality Electrodynamics and SpaceOAR hydrogel.

What products or services does BioProtect offer?

BioProtect offers BioProtect Balloon Implant System.

Who are BioProtect's investors?

BioProtect has 9 investors. Key investors include Medtronic, European Union, KB Investment, Xenia Venture Capital, and Peregrine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available